The CB013 embryonic stem cell line was established using day 3.5 blastocysts from a cross between a homozygous B6;129-Psen1tm1Mpm Tg(APPSwe,tauP301L)1Lfa/Mmjax female (MMRRC #034830/JAX#004807) and a male homozygous for Mapttm1(EGFP)Klt . This cross resulted in biological replicates that are heterozygous/hemizygous for Psen1tm1Mpm and Tg(APPSwe,tauP301L)1Lfan (MMRRC#03557, #03558). The recommended wild type control is MMRRC#037551 . All lines are heterozygous for Mapttm1(EGFP)Klt . These cell lines have been proven useful in in vitro experiments directed towards differentiation of ESCs to cortical neurons. Cell lines were derived and maintained on mitomycin-C treated mouse embryonic fibroblast feeder cells (MEFs) derived from C57BL/6J embryos. This cell line was not germline tested.

Use of MICE only available to non-profit entities.

The CB013 embryonic stem cell line was established from a cross between a homozygous B6;129-Psen1tm1Mpm Tg(APPSwe,tauP301L)1Lfa/Mmjax (3XTg-AD) female (JAX#004807) and a male homozygous for Mapttm1(EGFP)Klt. This cell line may be useful in in vitro experiments directed towards differentiation of ESCs to cortical neurons expressing AD-relevant mutations.

This strain is hosted by NIH's MMRRC, which partners with JAX for the distribution of this and other strains. For additional information and to purchase, please visit the MMRRC site.